HCPCS Level IIdrugActive
J3394
Inj, lovotibeglogene autotem
BETOS: O1E
Effective: 2024-07-01
Referenced in 3 policies
Description
Injection, lovotibeglogene autotemcel, per treatment
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Lyfgenia
Manufacturer
Bluebird Bio, Inc.
HCPCS Dosage
Per Treatment
Billing Units
1.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.